| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |